Weekly topotecan regimen in the treatment of recurrent ovarian cancer: search for alternatives to upholding the quality of life

The main goals of the study were to evaluate the efficacy and safety of intravenous topotecan (Hycamtin) used in a dose of 4 mg/m2 on days 1, 8, and 15 of a 28-day course of therapy in patients with recurrent ovarian cancer. The study revealed a number of benefits from use of topotecan in patients w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: E. G. Novikova (Auteur), I. A. Korneyeva (Auteur), E. A. Ronina (Auteur), S. A. Shcheltsyna (Auteur), E. D. Pashanov (Auteur)
Format: Livre
Publié: ABV-press, 2014-08-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible